Patent Assignment
Reel/Frame 042261/0226
Change of Name
Recorded: 2017-05-03
Pages: 4
Assignor
ARGEN-X B.V.
Executed: 2014-05-28
Assignee
ARGEN-X N.V.
WILLEMSTRAAT 5, BREDA, 4811 AH, NETHERLANDS
Covered Property
(1)
Fcrn Antagonists and Methods of Use
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Feb 11, 2016
From: ULRICHTS, PETER; BLANCHETOT, CHRISTOPHE; DREIER, TORSTEN; DE HAARD, JOHANNES
To: ARGEN-X B.V.
Reel/Frame 037713/0261 →
Assignment of Assignor's Interest
Feb 11, 2016
From: WARD OBER, E. SALLY
To: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
Reel/Frame 037713/0604 →
Change of Name
Feb 26, 2018
From: ARGEN-X N.V.
To: ARGENX SE
Reel/Frame 045441/0013 →
Assignment of Assignor's Interest
Feb 26, 2018
From: ARGENX SE
To: ARGENX BVBA
Reel/Frame 045441/0032 →
Change of Name
Jun 30, 2022
From: ARGENX BVBA
To: ARGENX BV
Reel/Frame 060366/0545 →
Change of Name
Sep 14, 2022
From: ARGENX BVBA
To: ARGENX BV
Reel/Frame 061090/0578 →
Confirmatory License
Nov 14, 2022
From: UT SOUTHWESTERN MEDICAL CENTER
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 061933/0702 →